UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 13,
Pieris Pharmaceuticals (NASDAQ:PIRS)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Pieris Pharmaceuticals.
Pieris Pharmaceuticals (NASDAQ:PIRS)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Pieris Pharmaceuticals.

Notícias Pieris Pharmaceuticals, Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quarta, 15 de Maio de 2024 (3 semanas atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Quinta, 9 de Maio de 2024 (4 semanas atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Quarta, 14 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Quarta, 14 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Quarta, 14 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sexta, 2 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Quinta, 21 de Dezembro de 2023 (5 meses atrás) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Terça, 14 de Novembro de 2023 (7 meses atrás) • Edgar (US Regulatory)
Form 8-K/A - Current report: [Amend]
Quinta, 31 de Agosto de 2023 (9 meses atrás) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Quinta, 10 de Agosto de 2023 (10 meses atrás) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Quinta, 10 de Agosto de 2023 (10 meses atrás) • Edgar (US Regulatory)
Form 8-K - Current report
Terça, 18 de Julho de 2023 (11 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Pieris Pharmaceuticals, Inc.